These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16433580)

  • 1. Cost-effectiveness of pharmacotherapy for autoimmune hepatitis.
    Heneghan MA; Al-Chalabi T; McFarlane IG
    Expert Opin Pharmacother; 2006 Feb; 7(2):145-56. PubMed ID: 16433580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and novel immunosuppressive therapy for autoimmune hepatitis.
    Heneghan MA; McFarlane IG
    Hepatology; 2002 Jan; 35(1):7-13. PubMed ID: 11786954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic strategies for autoimmune hepatitis.
    Manns MP; Strassburg CP
    Dig Dis; 2011; 29(4):411-5. PubMed ID: 21894012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and future treatments of autoimmune hepatitis.
    Czaja AJ
    Expert Rev Gastroenterol Hepatol; 2009 Jun; 3(3):269-91. PubMed ID: 19485809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and prospective pharmacotherapy for autoimmune hepatitis.
    Czaja AJ
    Expert Opin Pharmacother; 2014 Aug; 15(12):1715-36. PubMed ID: 24961409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.
    Richardson PD; James PD; Ryder SD
    J Hepatol; 2000 Sep; 33(3):371-5. PubMed ID: 11019991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis.
    Park SW; Um SH; Lee HA; Kim SH; Sim Y; Yim SY; Seo YS; Ryu HS
    Clin Mol Hepatol; 2016 Jun; 22(2):281-5. PubMed ID: 27246353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes.
    Baven-Pronk AM; Coenraad MJ; van Buuren HR; de Man RA; van Erpecum KJ; Lamers MM; Drenth JP; van den Berg AP; Beuers UH; den Ouden J; Koek GH; van Nieuwkerk CM; Bouma G; Brouwer JT; van Hoek B
    Aliment Pharmacol Ther; 2011 Aug; 34(3):335-43. PubMed ID: 21668459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis.
    Efe C; Taii HA; Ytting H; Aehling N; Bhanji RA; Hagström H; Purnak T; Muratori L; Werner M; Muratori P; Klintman D; Schiano TD; Montano-Loza AJ; Berg T; Larsen FS; Alkhouri N; Ozaslan E; Heneghan MA; Yoshida EM; Wahlin S
    Dig Dis Sci; 2018 May; 63(5):1348-1354. PubMed ID: 29569003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine.
    Giannakopoulos G; Verbaan H; Friis-Liby IL; Sangfelt P; Nyhlin N; Almer S;
    Dig Liver Dis; 2019 Feb; 51(2):253-257. PubMed ID: 30389427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Everolimus treatment for patients with autoimmune hepatitis and poor response to standard therapy and drug alternatives in use.
    Ytting H; Larsen FS
    Scand J Gastroenterol; 2015 Aug; 50(8):1025-31. PubMed ID: 25862144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autoimmune hepatitis: new diagnostic and therapeutic approach].
    Prelipcean CC; Mihai C; Stefănescu C; Drug VL
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):32-9. PubMed ID: 15688753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis.
    van de Nadort C; Houwen RH; Stapelbroek JM
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):490. PubMed ID: 18030221
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug therapy in the management of type 1 autoimmune hepatitis.
    Czaja AJ
    Drugs; 1999 Jan; 57(1):49-68. PubMed ID: 9951951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and therapy of autoimmune hepatitis.
    Granito A; Muratori P; Ferri S; Pappas G; Quarneti C; Lenzi M; Bianchi FB; Muratori L
    Mini Rev Med Chem; 2009 Jun; 9(7):847-60. PubMed ID: 19519509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil as a rescue therapy for autoimmune hepatitis patients who are not responsive to standard therapy.
    Fallatah HI; Akbar HO
    Expert Rev Gastroenterol Hepatol; 2011 Aug; 5(4):517-22. PubMed ID: 21780898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difficult treatment decisions in autoimmune hepatitis.
    Czaja AJ
    World J Gastroenterol; 2010 Feb; 16(8):934-47. PubMed ID: 20180231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of azathioprine metabolites in pediatric patients with autoimmune hepatitis.
    Nguyen TM; Daubard M; Le Gall C; Larger M; Lachaux A; Boulieu R
    Ther Drug Monit; 2010 Aug; 32(4):433-7. PubMed ID: 20479703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis.
    Efe C; Hagström H; Ytting H; Bhanji RA; Müller NF; Wang Q; Purnak T; Muratori L; Werner M; Marschall HU; Muratori P; Gunşar F; Klintman D; Parés A; Heurgué-Berlot A; Schiano TD; Cengiz M; May-Sien Tana M; Ma X; Montano-Loza AJ; Berg T; Verma S; Larsen FS; Ozaslan E; Heneghan MA; Yoshida EM; Wahlin S
    Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1950-1956.e1. PubMed ID: 28603052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of autoimmune hepatitis.
    Czaja AJ
    Semin Liver Dis; 2002 Nov; 22(4):365-78. PubMed ID: 12447708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.